These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3156659

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis.
    Marshall JF, Navarrete R, Joyce JN.
    Brain Res; 1989 Jul 31; 493(2):247-57. PubMed ID: 2527583
    [Abstract] [Full Text] [Related]

  • 24. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ.
    Crawford CA, Rowlett JK, McDougall SA, Bardo MT.
    Eur J Pharmacol; 1994 Feb 03; 252(2):225-31. PubMed ID: 8157063
    [Abstract] [Full Text] [Related]

  • 25. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC, Crossman AR, Woodruff GN.
    Brain Res; 1990 Apr 23; 514(1):93-102. PubMed ID: 2113410
    [Abstract] [Full Text] [Related]

  • 26. Dopamine receptor turnover rates in rat striatum are age-dependent.
    Leff SE, Gariano R, Creese I.
    Proc Natl Acad Sci U S A; 1984 Jun 23; 81(12):3910-4. PubMed ID: 6587399
    [Abstract] [Full Text] [Related]

  • 27. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
    Gagnon C, Bédard PJ, Rioux L, Gaudin D, Martinoli MG, Pelletier G, Di Paolo T.
    Brain Res; 1991 Sep 06; 558(2):251-63. PubMed ID: 1838295
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
    Xu SX, Hatada Y, Black LE, Creese I, Sibley DR.
    J Pharmacol Exp Ther; 1991 May 06; 257(2):608-15. PubMed ID: 1674530
    [Abstract] [Full Text] [Related]

  • 31. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
    Korf J, Sebens JB.
    J Neurochem; 1987 Feb 06; 48(2):516-21. PubMed ID: 2878979
    [Abstract] [Full Text] [Related]

  • 32. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP, Wooten GF.
    Ann Neurol; 1986 Apr 06; 19(4):378-83. PubMed ID: 3707090
    [Abstract] [Full Text] [Related]

  • 33. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
    Battaglia G, Norman AB, Newton PL, Creese I.
    J Neurochem; 1986 Feb 06; 46(2):589-93. PubMed ID: 2934516
    [Abstract] [Full Text] [Related]

  • 34. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY, Martin-Iverson MT.
    Synapse; 1993 Jan 06; 13(1):20-9. PubMed ID: 8093985
    [Abstract] [Full Text] [Related]

  • 35. Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity.
    Neve KA, Kozlowski MR, Marshall JF.
    Brain Res; 1982 Jul 22; 244(1):33-44. PubMed ID: 6288182
    [Abstract] [Full Text] [Related]

  • 36. Nondopaminergic prefrontocortical efferent fibers modulate D1 receptor denervation supersensitivity in specific regions of the rat striatum.
    Herve D, Trovero F, Blanc G, Thierry AM, Glowinski J, Tassin JP.
    J Neurosci; 1989 Nov 22; 9(11):3699-708. PubMed ID: 2479723
    [Abstract] [Full Text] [Related]

  • 37. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 22; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 38. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM, Dawson VL, Gage FH, Fisher LJ, Hunt MA, Wamsley JK.
    Brain Res; 1991 Feb 01; 540(1-2):145-52. PubMed ID: 1905173
    [Abstract] [Full Text] [Related]

  • 39. Differential effect of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on [3H]SCH23390 and [3H]forskolin binding in rat striatum.
    Norman AB, Wachendorf TJ, Sanberg PR.
    Life Sci; 1989 Feb 01; 44(13):831-6. PubMed ID: 2648096
    [Abstract] [Full Text] [Related]

  • 40. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
    Meller E, Bohmaker K, Goldstein M, Friedhoff AJ.
    J Pharmacol Exp Ther; 1985 Jun 01; 233(3):656-62. PubMed ID: 2861276
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.